Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
23.93
+0.06 (0.25%)
Oct 21, 2026, 4:00 PM EDT - Market closed

Biodesix Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
25254223166176143
Market Cap Growth
388.98%-75.69%33.69%-5.38%23.06%-73.28%
Enterprise Value
294110253197184125
Last Close Price
23.936.8030.6036.8046.00105.80

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.450.613.123.394.602.62
PB Ratio
27.61-21.9510.6636.358.547.25

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.861.253.554.024.822.29

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
7.85-29.552.9713.251.550.51
Net Debt / Equity Ratio
4.57-21.851.717.51-0.55-1.15
Net Debt / EBITDA Ratio
-2.79-2.44-1.25-0.910.240.63
Net Debt / FCF Ratio
-2.06-2.29-0.69-0.750.230.75
Asset Turnover
1.130.960.730.510.450.55
Inventory Turnover
12.8614.5412.989.296.5810.01
Quick Ratio
2.561.612.431.022.111.26
Current Ratio
2.851.872.761.192.341.51
Return on Equity (ROE)
-540.01%-383.09%-337.30%-414.09%-324.53%-141.75%
Return on Assets (ROA)
-14.05%-18.79%-21.81%-26.89%-37.36%-24.93%
Return on Capital Employed (ROCE)
-25.70%-39.60%-41.30%-62.90%-72.10%-83.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.06%-65.19%-19.29%-31.32%-37.20%-30.19%
FCF Yield
-8.02%-43.49%-23.31%-27.51%-27.44%-21.31%
Buyback Yield / Dilution
-21.27%-16.71%-57.59%-95.03%-53.86%-465.63%
SEC Filings: 10-K · 10-Q